3D Bioprinting of Tumor Models for Cancer Research
The DOI matches its Crossref record; 239 of the 241 references it cites were found in a registry or an index.
Abstract
The exact mechanistic understanding of cancer metastasis continues to be unknown, although it is a major cause of death worldwide. Along with the tumor mass, the tumor microenvironment also contributes to pathogenesis and treatment resistance. Tumors are characterized by a high degree of heterogeneity and complexity. However, the fabrication of suitable in vitro models of the microenvironment is difficult as two-dimensional (2D) models do not completely recapitulate the biochemical and biophysical signals of the tumor environment. Thus, three-dimensional (3D) tumor models are emerging as vital tools for the comprehensive understanding of the sophisticated disease. Among different 3D models such as spheroid cultures, biopolymer scaffolds, organ on chip, and ex vivo tissue slices, 3D bioprinting has a competitive advantage due to the ability to precisely control and define the desired structure and position of multiple types of cells in a high-throughput manner. In this Review, we discussed the 3D bioprinted tumor models that integrate their microenvironment with different cell types, substrates, and bioprinting modalities and their application in drug screening and therapy. Finally, we highlighted the comprehensive understanding of the cancer microenvironment by 3D printed tumor models that are more physiologically relevant than the other models and expounded the challenges that need to be addressed for the clinical translation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Matrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Edmondson, R., Broglie, J. J., Adcock, A. F., & Yang, L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.573 · Cited by 2,515
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Alginate hydrogels as synthetic extracellular matrix materials
Rowley, J. A., Madlambayan, G., & Mooney, D. J. (1999) · Biomaterials · doi:10.1016/s0142-9612(98)00107-0 · Cited by 2,342
3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs
Kolesky, D. B., Truby, R. L., Gladman, A. S., Busbee, T. A., Homan, K. A., & Lewis, J. A. (2014) · Advanced Materials · doi:10.1002/adma.201305506 · Cited by 2,102
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Research works printed but not linked: 6
- Cirri P., 2011, Am. J. Cancer Res., 1, 482
- Soranzo C., 1998, Anticancer Res., 8, 369
- Langmuir V. K., 1989, Cancer Res., 49, 3401
- Jin Y., 2015, Int. J. Clin. Exp. Med., 8, 9911
- 10.1088/1758-5082/6/3/035001 · DOI · Paper page
- 10.1088/1758-5090/aafc49 · DOI · Paper page
Cited by
Items 101–114 of 114
Cho, W.-W., Park, W., Cho, D., & Yi, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823536-2.00003-1
王, 晗. (2023) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2023.134042
New tools for understanding cancer evolution and drug resistance
Källberg, J. (2022) · theses.fr (ABES) · doi:10.70675/51bc11abzb90bz4c3az9418z3fd1486f4e56
4D EPR Oximetry Imaging for 4D Bioprinting and Tissue Engineering
Sarvari, S. (2024) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12500
Bioprinting of engineering tissue constructs in medical science: A brief cancer overview
Wilson, D. W., Buttar, H. S., & Tuli, H. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00057-7
3D bioprinting for recapitulation of tumor microenvironment
Kar, S., Panda, S., Mishra, S., Mohapatra, A. P., & Senapati, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26518-1.00008-2
Khoshtabiat, L., Meshkini, A., & Matin, M. M. (2024) · Figshare · doi:10.6084/m9.figshare.26583999
Optical Techniques for Tissue Engineering and Massive Neural Sensing
Babayiğit, C. (2025) · eScholarship (California Digital Library)
Development and characterization of personalized magnetic spheroids as advanced 3D tumor models
Soares, M. D. C. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tomar, P., Salmani, M. S., Srivastav, N. K., & Jindal, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-6774-4_12
Paracrine Signaling in Cell–Biomaterial Interactions in Scaffold Vascularization: A Mini Review
Cole, A., & Sultana, N. (2026) · Biomimetics · doi:10.3390/biomimetics11070492
Advances in stem cell-based oncology: Therapeutic mechanism, nanotechnology, and synergies
Thorat, D. S., Jat, S., Joshi, A., Singh, S., Nwabor, L. C., Ushir, Y. V., Thorat, S., & Singh, S. (2026) · Next research. · doi:10.1016/j.nexres.2026.102177
Douglas, Y. K., & Adham, S. A. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08763-1
“Moreover, the pharmaceutical sector faces resistance to adopting 3D models because many existing drug development workflows are optimized for 2D cultures and animal models, meaning the shift to 3D models requires expensive retooling of both infrastructure and specialized personnel [269, 273].”
Scocozza, F., & Conti, M. (2026) · Advances in chemical engineering · doi:10.1016/bs.ache.2026.08.002
Metadata
- Authors
- Kang, Y., Datta, P., Shanmughapriya, S., & Ozbolat, I. T.
- Affiliations
- The Huck Institutes of the Life Sciences, Penn State University, University Park, Pennsylvania 16802, United States
- Indian Institute of Engineering Science and Technology, Shibpur (IN)
- Pennsylvania State University (US)
- Corresponding author
- Ozbolat, Ibrahim T.
- Venue
- ACS Applied Bio Materials
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-08-10
- Volume
- 3
- Issue
- 9
- Pages
- 5552-5573
- ISSN
- 2576-6422 (ISSN-L)
- OpenAlex
- W3048874737
- Cited by
- 112
- References
- 241
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 18 · 2023: 32 · 2022: 13 · 2021: 16 · 2020: 1
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Applied Bio Materials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R21 CA224422)
- Department of Science and Technology, Ministry of Science and Technology
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- 3D bioprinting, tumor models, tumor microenvironment, metastasis, tumor heterogeneity, spheroid culture, biopolymer scaffolds, organ-on-a-chip, drug screening, cancer therapy, clinical translation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.